The Ministry of Public Health on Wednesday signed a procurement agreement with AstraZeneca for 257,500 doses of the long-acting antibody drug Evusheld, which boosts Covid-19 immunity in patients with low immunity levels. The first group of beneficiaries is expected to be patients living with kidney disease. Health Minister Anutin Charnvirakul said the ministry was intent on maintaining a balance of medical resources to combat Covid-19, especially a stockpile of vaccines and medical treatments. There was enough vaccine in stock. The vaccine from AstraZeneca was the country’s main Covid-19 vacci…

Read More